A number of disease- or host-related markers have been proposed to predict treatment outcome in relapsed/refractory Hodgkin lymphoma (HL). In this issue of Blood , Moskowitz et al demonstrate that fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) performed in sequence during second-line treatment recapitulates all of them. 1

中文翻译：

---

复发/难治性 HL：FDG-PET 是王牌

许多疾病或宿主相关标志物已被提议用于预测复发/难治性霍奇金淋巴瘤 (HL) 的治疗结果。在本期 Blood 中，Moskowitz 等人证明，在二线治疗期间依次进行的氟脱氧葡萄糖 (FDG)-正电子发射断层扫描 (PET)/计算机断层扫描 (CT) 概括了所有这些。1